Latest Share Purchase Plan News

AIC Mines reports robust production and cash flow from Eloise, advances Jericho development with promising drilling, and kicks off a major processing plant expansion.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

Hillgrove Resources has initiated production blasting at the Nugent deposit, accelerating its expansion plans for the Kanmantoo copper mine and aiming to increase mining throughput by early 2026.

Theta Gold Mines has completed a significant capital raising, securing nearly A$20 million through a placement and the first tranche of a cornerstone investment, setting the stage for advancing its TGME Gold Project.

Barton Gold Holdings has raised $17.5 million through a placement led by Franklin Templeton and a Share Purchase Plan, aiming to commission its Central Gawler Mill by late 2026 and advance the Tunkillia Gold Project.

Peel Mining Limited has announced the early closure of its Share Purchase Plan due to overwhelming shareholder interest, signaling robust support ahead of the capital raise completion.

Catapult Sports has successfully completed a A$130 million institutional placement to fund its strategic acquisition of IMPECT GmbH, a leader in soccer analytics software. The company also launched a A$20 million Share Purchase Plan to engage existing shareholders.

Paladin Energy reported a record uranium production quarter at its Langer Heinrich Mine alongside a successful A$300 million equity raise, positioning the company for accelerated development of its Patterson Lake South project.

Canterbury Resources is on the cusp of completing a pivotal scoping study for its Briggs Copper Project, while deep drilling advances to unlock higher-grade mineralisation. The company also moves forward with new exploration initiatives and a share purchase plan to bolster funding.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

INOVIQ Limited has raised $11.5 million through a $9.5 million placement and a $2 million share purchase plan to accelerate the development and commercialisation of its EXO-OC ovarian cancer test and exosome therapeutic program.

Catapult Sports Ltd has announced a strategic acquisition of German soccer analytics firm Impect GmbH, funded by a fully underwritten A$130 million placement and a share purchase plan. This move enhances Catapult’s platform with advanced scouting and tactical insights, positioning the company for accelerated growth.